Phil Carroll and Kevin Hornsby talk to Geoff and Che about their recent US investor roadshow. The company aims to maximize the potential of its listing on the OTCQB market and engage proactively with the US investment community. To support its investor relations and corporate communications activities in the US, BSF has appointed Skyline Corporate Communications Group, LLC as its US Investor Relations agency. Additionally, BSF will participated in the Future Food Tech Summit in New York City and raised its profile with prospective partners and investors in the alternative proteins sector. The company has also established a subsidiary called BSF Enterprise (Hong Kong) Ltd and opened an office in Hong Kong. This strategic move aims to provide access to the Greater China market, which has a significant demand for meat and a thriving biopharmaceutical industry. 3D Bio-Tissues' patented culture media supplement, City-MixTM, offers advantages in the production of cultivated meat and targets the biotech and life sciences sectors in the region. With China's inclusion of cultivated meat in its agricultural plan, the new subsidiary will facilitate the expansion of 3D Bio-Tissues' global network and partnerships.

The information, investment views, and recommendations in this podcast are provided for general information purposes only. Nothing in this podcast should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.